TABLE 1.
Clinical characteristic of cancer and healthy participants.
| Breast cancer | Colorectal cancer | Gastric cancer | Liver cancer | Lung cancer | All cancers | Healthy control | |
|---|---|---|---|---|---|---|---|
| N | 64 | 59 | 62 | 29 | 41 | 255 | 304 |
| Stage | |||||||
| I (N, %) | 10 (15.6%) | 4 (6.8%) | 12 (19.4%) | 9 (31.0%) | 1 (2.4%) | 36 (14.1%) | |
| II (N, %) | 44 (68.8%) | 19 (32.2%) | 16 (25.8%) | 12 (41.4%) | 1 (2.4%) | 92 (36.1%) | |
| IIIA (N, %) | 6 (9.4%) | 13 (22.0%) | 22 (35.5%) | 8 (27.6%) | 22 (53.7%) | 71 (27.8%) | |
| Non‐metastatic with unknown staging | 4 (6.3%) | 23 (39.0%) | 12 (19.4%) | 0 (0%) | 17 (41.5%) | 56 (22.0%) | |
| Age (range) | 52 (28–75) | 63 (32–83) | 62.5 (38–84) | 59 (32–71) | 66 (34–79) | 60 (28–84) | 50 (40–79) |
| Mann–Whitney U test (p‐value = 8.62e‐18) | |||||||
| Gender | Chi‐squared (p‐value = 0.9999) | ||||||
| Male | 0 (0%) | 32 (54.2%) | 33 (59%) | 25 (86.2%) | 25 (61.0%) | 115 (45.1%) | 136 (44.7%) |
| Female | 64 (100%) | 27 (45.8%) | 29 (46.8%) | 4 (13.8%) | 16 (39.0%) | 140 (54.9%) | 168 (55.3%) |